Jazz Pharmaceuticals plc Unrecorded Unconditional Purchase Obligation, to be Paid, Year One
Jazz Pharmaceuticals plc (JAZZ) had Unrecorded Unconditional Purchase Obligation, to be Paid, Year One of $90.50 million as of 2020-03-31, per its 10-Q filed 2020-05-05.
Discontinued › Notes › Commitment and Contingencies › Unrecorded Unconditional Purchase Obligation, Fiscal Year Maturity
us-gaap:UnrecordedUnconditionalPurchaseObligationBalanceOnFirstAnniversary · last filed 2020-05-05
- 2020-03-31: Unrecorded Unconditional Purchase Obligation, to be Paid, Year One $90.50M.
- 2019-12-31: Unrecorded Unconditional Purchase Obligation, to be Paid, Year One $74.50M.
- 2019-09-30: Unrecorded Unconditional Purchase Obligation, to be Paid, Year One $79.80M.
- 2019-06-30: Unrecorded Unconditional Purchase Obligation, to be Paid, Year One $69.60M.
| Period end | Unrecorded Unconditional Purchase Obligation, to be Paid, Year One |
|---|---|
| 2020-03-31 | $90.50M 10-Q · filed 2020-05-05 |
| 2019-12-31 | $74.50M 10-K · filed 2020-02-25 |
| 2019-09-30 | $79.80M 10-Q · filed 2019-11-05 |
| 2019-06-30 | $69.60M 10-Q · filed 2019-08-06 |
| 2019-03-31 | $70.30M 10-Q · filed 2019-05-07 |
| 2018-12-31 | $65.10M 10-K · filed 2019-02-26 |
| 2018-09-30 | $54.70M 10-Q · filed 2018-11-06 |
| 2018-06-30 | $62.60M 10-Q · filed 2018-08-07 |
| 2018-03-31 | $74.40M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $46.30M 10-K · filed 2018-02-27 |
| 2017-09-30 | $43.20M 10-Q · filed 2017-11-07 |
| 2017-06-30 | $31.40M 10-Q · filed 2017-08-08 |
| 2017-03-31 | $31.90M 10-Q · filed 2017-05-09 |
| 2016-12-31 | $27.10M 10-K · filed 2017-02-28 |
| 2016-09-30 | $23.10M 10-Q · filed 2016-11-08 |
| 2016-06-30 | $27.00M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $53.40M 10-Q · filed 2016-05-10 |
| 2015-12-31 | $97.50M 10-K · filed 2016-02-23 |
| 2015-09-30 | $25.60M 10-Q · filed 2015-11-09 |
| 2015-06-30 | $36.40M 10-Q · filed 2015-08-05 |
| 2015-03-31 | $27.40M 10-Q · filed 2015-05-07 |
| 2014-12-31 | $34.60M 10-K · filed 2015-02-24 |
| 2014-09-30 | $25.70M 10-Q · filed 2014-11-04 |
| 2014-06-30 | $37.40M 10-Q · filed 2014-08-05 |
| 2014-03-31 | $36.90M 10-Q · filed 2014-05-08 |
| 2013-12-31 | $52.00M 10-K · filed 2014-02-25 |
| 2013-09-30 | $68.10M 10-Q · filed 2013-11-05 |
| 2013-06-30 | $34.50M 10-Q · filed 2013-08-06 |
| 2013-03-31 | $55.10M 10-Q · filed 2013-05-07 |
| 2012-12-31 | $70.10M 10-K · filed 2013-02-26 |
| 2012-06-30 | $42.50M 10-Q · filed 2012-08-07 |
| 2012-03-31 | $9.80M 10-Q · filed 2012-05-08 |
| 2011-12-31 | $5.70M 10-K · filed 2013-02-26 |
| 2010-12-31 | $2.10M 10-K · filed 2012-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |